A study (Sanesi et al., 2023) examining the effects of FNDC5/irisin on muscle atrophy revealed that after 4 weeks of muscle atrophy, FNDC5 levels and serum irisin concentrations decreased. The gene discussed is FNDC5; the disease is muscle atrophy.